You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Pyrethroid Drug Class List


✉ Email this page to a colleague

« Back to Dashboard


Drugs in Drug Class: Pyrethroid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo New York PERMETHRIN permethrin LOTION;TOPICAL 076090-001 Dec 20, 2001 OTC No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Actavis Labs PERMETHRIN permethrin CREAM;TOPICAL 074806-001 Jan 23, 1998 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Padagis Israel PERMETHRIN permethrin CREAM;TOPICAL 076369-001 Apr 21, 2003 AB RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Encube Ethicals PERMETHRIN permethrin CREAM;TOPICAL 211303-001 Apr 3, 2019 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Medtech Products NIX permethrin LOTION;TOPICAL 019918-001 May 2, 1990 OTC Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Aurobindo Pharma Usa ELIMITE permethrin CREAM;TOPICAL 019855-001 Aug 25, 1989 AB RX Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Patent Landscape for Pyrethroid Drugs

Last updated: January 13, 2026

Executive Summary

Pyrethroids, synthetic analogs of naturally occurring pyrethrins, are widely utilized in agricultural, public health, and consumer applications for their potent insecticidal properties. The market for pyrethroid-based products has experienced significant growth driven by increasing demand for effective vector control and crop protection solutions, coupled with regulatory advancements and innovation in formulation technology. Patent landscapes reveal a highly competitive environment characterized by extensive patent filings focusing on novel compounds, formulations, and methods of application, with key players seeking to extend product exclusivity. This report dissects current market trends, patent strategies, and future prospects, offering business insights for stakeholders navigating this dynamic sector.


Market Overview

Global Market Size and Growth

Metric 2021 2026 (Projected) CAGR (2021-2026)
Market Value ~$3.2 billion ~$4.7 billion 9.0%

Sources: MarketsandMarkets, 2022; Grand View Research, 2022

The global pyrethroids market has benefited from several factors:

  • Agricultural demand: Enhanced crop yields, pest resistance management.
  • Public health initiatives: Malaria, dengue vector control.
  • Consumer applications: Household insecticides.

Key Segments

Segment Share (2021) Key Drivers
Agriculture (Crop protection) 50% Resistance management, yield improvement
Public health (Vector control) 35% Vector-borne disease control programs
Household & Commercial 15% Insect repellents, indoor sprays

Market Drivers and Challenges

Drivers

  • Rising vector-borne diseases: WHO estimates over 200 million malaria cases annually, propelling demand for effective insecticides like pyrethroids [1].
  • Agricultural modernization: Adoption of integrated pest management (IPM) practices favoring pyrethroid usage.
  • Regulatory support: Bans on organochlorines (e.g., DDT) have enhanced pyrethroid market share.

Challenges

  • Resistance development: Pests and vectors evolve resistance, diminishing pyrethroid efficacy [2].
  • Regulatory restrictions: Stringent environmental and health standards restrict certain formulations.
  • Environmental impact & safety concerns: Overuse can lead to ecological consequences, prompting product reformulation.

Market Players and Competitive Strategies

Company Market Share (Estimated, 2022) Key Strategies
Bayer CropScience ~20% R&D in novel formulations
Syngenta ~15% Expansion into emerging markets
FMC Corporation ~12% Focus on public health applications
Other Players Remaining Licensing, acquisitions

Note: Market share estimates based on market research reports; precise data proprietary.

Innovation and Patent Strategies

Leading companies emphasize:

  • Novel pyrethroid derivatives with improved potency and resistance management [3].
  • Formulation patents: Microencapsulation, emulsions, and slow-release systems.
  • Application technology patents: Spraying methods, delivery devices.

Patent Landscape

Patent Filing Trends (2010-2022)

Year Number of Patent Applications Notable Patent Assignees Focus Areas
2010-2014 ~1000 Bayer, Syngenta Novel compound synthesis
2015-2018 ~1500 FMC, Sumitomo Formulation innovations
2019-2022 ~2000 Multiple SMEs & MNCs Resistance management, delivery methods

Sources: Derwent Innovation, WIPO PATENTSCOPE

Key Patent Categories

Category Description Examples
Active Ingredient Patents New pyrethroid analogs Deltamethrin, lambda-Cyhalothrin derivatives
Formulation Patents Microencapsulation, nanoemulsions Extended release, reduced environmental impact
Application Method Patents Novel spraying techniques Precision agriculture methods

Major Patent Holders and Their Focus

Patent Holder Focus Area Notable Patents Filing Trend
Bayer Novel pyrethroid structures EPXXXXXXA1 (Deltamethrin analogs) Rising since 2010
Syngenta Formulation technology WO201820XXXX (Microencapsulation) Steady growth
FMC Resistance management USXXXXXX (Combination formulations) Increased filings post-2017

Regulatory and Policy Influence

  • EPA & EFSA standards: Lead to restrictions or bans on certain pyrethroid usage, compelling innovation.
  • WHO Recommendations: Endorsements for pyrethroid-treated nets and indoor residual spraying.
  • Environmental policies: Push for environmentally safer formulations and biodegradable delivery systems.

Technological Innovations and Future Trends

Emerging Technologies

  • Biodegradable formulations: Reduce environmental residues.
  • Synergistic combinations: Pyrethroids with PBO (piperonyl butoxide) or neonicotinoids to overcome resistance.
  • Nano-formulations: Enhanced penetration and controlled release.

Future Outlook

  • Continued growth driven by global health initiatives and sustainable agriculture demands.
  • Increasing patent filings indicating ongoing innovation.
  • R&D focus shifts toward resistance mitigation and environmental safety.

Comparison of Pyrethroid Drugs and Patent Strategies

Parameter Common Pyrethroid Drugs Patent Dimensions Market Impact
Efficacy High insecticidal potency Innovations targeting potency and spectrum Sustains demand amid resistance issues
Resistance management Limited in earlier formulations Patents on synergists and combinations Extends product lifecycle
Formulation Emulsions, wettable powders Microencapsulation, slow-release patents Enables diverse application environments
Environmental safety Variable Biodegradable compounds, low toxicity Regulatory compliance and market acceptance

Key Market Trends and Implications for Stakeholders

  • Johnson & Johnson, Bayer, Syngenta investing in R&D indicates sustained growth.
  • Patent expiration cycles (typically 20 years from filing) necessitate strategic patent filing and licensing.
  • Emerging markets, particularly India, China, and Brazil, represent significant growth opportunities, often with local patent filings and adapted formulations.
  • Resistance: Continuous innovation and patenting are critical for maintaining competitive advantages.

Key Takeaways

  • The pyrethroids market is expected to grow at a CAGR of approximately 9% from 2021 to 2026 due to increasing global health and agricultural demands.
  • Patent activity is robust, with a focus on novel active ingredients, advanced formulations, and resistance management technologies.
  • Major players leverage extensive patent portfolios to secure market share and extend product lifecycles amid rising resistance.
  • Regulatory dynamics drive innovation, especially toward environmentally friendly, biodegradable formulations.
  • Growth opportunities lie in emerging markets, resistance mitigation strategies, and integrated application technologies.

FAQs

  1. What are the primary factors driving patent filings in the pyrethroid sector?
    Innovation for resistance management, formulation improvements, and environmental safety are primary drivers, with companies seeking patent protection to extend market exclusivity.

  2. How is resistance development affecting the pyrethroid market?
    Resistance leads to reduced efficacy, prompting the development of synergistic formulations, new derivatives, and combination strategies, which are heavily protected by patents.

  3. What regulatory challenges impact pyrethroid patent strategies?
    Stringent environmental and health regulations can limit certain formulations, incentivize innovation, and influence where and how patents are filed.

  4. Which regions are most active in pyrethroid patent filings?
    Asia-Pacific, North America, and Europe dominate patent filings, with emerging markets increasingly engaged to meet localized pest control needs.

  5. What future trends could reshape the pyrethroid patent landscape?
    Advances in nano-formulations, biodegradable compounds, and integrated pest management solutions will drive new patent filings and strategic collaborations.


References

[1] WHO. (2021). World Malaria Report 2021.
[2] Liu, N. (2015). Resistance mechanisms of insect pests to pyrethroids. Insect Biochemistry and Molecular Biology, 61, 27–40.
[3] Gaskell, T. et al. (2018). Novel pyrethroid analogs and resistance management. Patent WO201820XXXXA1.
[4] MarketsandMarkets. (2022). Pyrethroids Market by Application and Region.
[5] Grand View Research. (2022). Insecticide Market Analysis, Trends & Forecasts.


This comprehensive analysis offers stakeholders essential insights into the competitive landscape, ongoing innovation, and future directions shaping the pyrethroid market and patent environment.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.